Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.9900
-0.0300 (-2.94%)
May 11, 2026, 4:00 PM EDT - Market closed
Standard BioTools Employees
As of December 31, 2025, Standard BioTools had 389 total employees, including 385 full-time and 4 part-time employees. The number of employees decreased by 429 or -52.44% compared to the previous year.
Employees
389
Change (1Y)
-429
Growth (1Y)
-52.44%
Revenue / Employee
$221,735
Profits / Employee
$201,041
Market Cap
386.46M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 389 | -429 | -52.44% | 385 | 4 |
| Dec 31, 2024 | 818 | 279 | 51.76% | 814 | 4 |
| Dec 31, 2023 | 539 | 16 | 3.06% | 534 | 5 |
| Dec 31, 2022 | 523 | -92 | -14.96% | 523 | 0 |
| Dec 31, 2021 | 615 | -12 | -1.91% | 615 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,400 |
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,382 |
| OrthoPediatrics | 602 |
| Pacific Biosciences of California | 485 |
| Beta Bionics | 423 |
| ClearPoint Neuro | 172 |
| Perspective Therapeutics | 166 |
LAB News
- 6 days ago - Standard BioTools Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 2 months ago - Standard BioTools reports Q4 EPS 5c vs (9c) last year - TheFly
- 2 months ago - Standard BioTools sees FY26 revenue $80M-$85M, consensus $79.73M - TheFly
- 2 months ago - Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 3 months ago - Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 3 months ago - Standard BioTools completes sale of SomaLogic to Illumina - TheFly
- 3 months ago - Standard BioTools Completes Sale of SomaLogic to Illumina - GlobeNewsWire
- 4 months ago - Standard BioTools sees Q4 revenue from cont. ops. $24M, consensus $18.5M - TheFly